PD Dr. Markus Eckstein



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Chronic hearing loss turns out being a calcified chondroid mesenchymal neoplasm with FN1::FGFR2 fusion (2024) Bauerschmitz L, Agaimy A, Eckstein M, Balk M, Iro H, Schleder S, Schlaffer SM, Gostian AO Journal article Pre-treatment metastatic biopsy: a step towards precision oncology for urothelial cancer (2024) Klümper N, Cox A, Sjödahl G, Roghmann F, Bolenz C, Hartmann A, Grünwald V, et al. Journal article, Review article Harnblase: Tumorvorstufen und nichtinvasive Karzinome (2024) Lange F, Hartmann A, Eckstein M Journal article CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series (2024) Auth J, Müller F, Völkl S, Bayerl N, Distler JH, Tur C, Raimondo MG, et al. Journal article AI allows pre-screening of FGFR3 mutational status using routine histology slides of muscle-invasive bladder cancer. (2024) Bannier PA, Saillard C, Mann P, Touzot M, Maussion C, Matek C, Klümper N, et al. Journal article Das muskelinvasive und metastasierte Urothelkarzinom aus Sicht der Pathologie (2024) Klümper N, Kalogirou C, Eckstein M Journal article, Review article Explainable convolutional neural networks for assessing head and neck cancer histopathology (2023) Dörrich M, Hecht M, Fietkau R, Hartmann A, Iro H, Gostian AO, Eckstein M, Kist A Journal article Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial) (2023) Breyer J, Eckstein M, Sikic D, Wezel F, Roghmann F, Brehmer M, Wirtz RM, et al. Journal article Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approach (2023) Henderson RH, French D, Stewart E, Smart D, Idica A, Redmond S, Eckstein M, et al. Journal article Author Correction: CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression (Scientific Reports, (2023), 13, 1, (73), 10.1038/s41598-022-26579-z) (2023) Saponaro M, Flottmann S, Eckstein M, Hommerding O, Klümper N, Corvino D, Hosni S, et al. Journal article, Erratum